Assay kits are used to carry out analyses in a broad scope of applications including the study of targets such as drugs, molecules, disease pathways, chemical elements or compounds, and organisms. They are a routine procedure in the modern pharmaceutical, medical and forensic world as well as research and university laboratories around the globe. Assay kits come with all the necessary reagents, instructions and protocols for fast and efficient processing, allowing for repeatable results.
|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | IGF-1 RIA | Angiotensin II RIA Assay | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) ELISA | Testosterone ELISA Assay | Triiodothyronine (Total) ELISA Assay |
| Citations | | | | | |
| Catalog Number | R20 | RB320 US | TM09003 | IB79106 | IB19107N |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Radioimmunoassay (RIA) for the quantitative in vitro diagnostic measurement of levels of Insulin-like Growth Factor-I (IGF-I) in serum or plasma. Human IGF-I measurements are used in the diagnosis and treatment of growth disorders involving the anterior lobe of the pituitary gland. FDA exempt, can Radioimmunoassay (RIA) for the quantitative in vitro diagnostic measurement of levels of Insulin-like Growth Factor-I (IGF-I) in serum or plasma. Human IGF-I measurements are used in the diagnosis and treatment of growth disorders involving the anterior lobe of the pituitary gland. FDA exempt, can be used for in-vitro diagnostics.... Read More | Radioimmunoassay (RIA) for the determination of angiotensin II in plasma (EDTA). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Infliximab (Remicade®, Remsima®, and Inflectra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the quantitative determination of Testosterone in serum and plasma. 510(k) cleared. | Solid phase competitive enzyme immunoassay (ELISA) for the determination of total T3 (Triiodothyronine) in human serum or plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | IGF-1 | GPIHBP1 Autoantibody | Prolactin | Testosterone | Triiodothyronine (Total) |
| Sample Type | Serum or plasma. | Serum, EDTA-plasma, heparin plasma, and post-heparin EDTA-plasma. | Serum, Blood Plasma | Serum, Blood Plasma | Serum, Blood Plasma |
| Method | Radio Immuno Assay (RIA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 0.156 - 10 ng/mL | 4.7 to 150.0 pmol/L | 0 / 1 - 30 ng/mL | 0.15 to 16 ng/mL | 0.5 to 7.5 ng/mL |
| Sensitivity | 0.064 µg/L | 0.001 U/mL | 0.35 ng/mL | 0.09 ng/mL | Inquire |
| Assay Time | 48 hour incubation (2-8°C) + 1 hour (2-8°C) + Centrifuge 30 min. (2-8°C) = 49 hours, 30 min. total incubation time. | 18 hrs 15 mins (incubation) | 2 hours, 15 min. total incubation time. | 1 hr 15 mins (incubation) | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |